Article Information
History
- December 24, 2020.
Article Versions
- Version 1 (November 24, 2020 - 22:31).
- Version 2 (December 23, 2020 - 09:49).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Joel Hellewell1,†,*,
- Timothy W. Russell1,†,
- The SAFER Investigators and Field Study Team2,
- The Crick COVID-19 Consortium3,
- CMMID COVID-19 working group1,
- Rupert Beale3,
- Gavin Kelly4,
- Catherine Houlihan4,5,6,
- Eleni Nastouli4,7 and
- Adam J. Kucharski1
- 1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, UK
- 2Department of Clinical Virology, University College London Hospitals, London W1T 4EU, UK
- 3Cell Biology of Infection Laboratory, The Francis Crick Institute; Division of Medicine, UCL, UK
- 4Bioinformatics and Biostatistics, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
- 5Department of Infection and Immunity, University College London, London, UK
- 6Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK
- 7Department of Population, Policy and Practice, UCL Great Ormond Street Institute of Child Health, London, WC1N 1EH UK
- ↵*Corresponding author: Joel Hellewell, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom. Email: joel.hellewell{at}lshtm.ac.uk.
↵† Authors contributed equally